Рифат Сафади

Должность: Гепатолог
Языки: Английский, Иврит
Принимает: только взрослых



Профессор Рифат Сафади

Образование

Родился 24-го января 1965 года. Выпускник Еврейского университета (1999 г). Проходил ординатуру в отделении общей терапии а затем при отделении гастроэнтерологии университетской клиники "Хадасса".

Специализация

Заведующий центром гепатологии.

Профессиональная деятельность

Член комитета по развитию центра трансплантации соматических клеток Старший врач в отделении лечения заболеваний печени Член Американской и Европейской ассоциаций по изучению печени Автор многочисленных научных публикаций.

Научные публикации

Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms and Biomarkers for Precision Therapy
Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies
Pediatric to adult transition in chronic kidney disease: a scoping review
Incidentally Detected Odontogenic Keratocyst With Inconclusive Histopathology: A Case Report Emphasizing Clinicoradiologic Correlation
Efficacy and safety of belapectin for the prevention of esophageal varices in patients with MASH cirrhosis: The randomized, placebo-controlled NAVIGATE trial
Her Health Behavior, Her Choice? Decision-Making Power Over Key Health and Nutrition Behaviors Among Pregnant and Lactating Women in Jordan
Templateless crystallization of holococcolith crystals visualized by intracellular site-specific three-dimensional microscopy
Spatial Relations between Coccoliths and Their Confining Membrane During Crystal Morphogenesis
Hepatitis B Vaccine Response in Children of Vaccinated Versus Unvaccinated Mothers: A Retrospective Cohort Study
Awareness and intended behavioral responses to oral potentially malignant disorders: an image-based assessment among dental clinic attendees in Jordan
The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist
Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study
Adjunctive Semaglutide in Patients Undergoing Intragastric Balloon for Weight Loss: 12-Month Prospective Comparative Study
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Cardiovascular Assessments in Children and Adolescents With Hypertension
SGLT2 Inhibitors in MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) Associated with Sustained Hepatic Benefits, Besides the Cardiometabolic
Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes
Association Between High FIB-4 Score and the Risk of Malignancy Development and Mortality: A Retrospective Longitudinal Case-Control Study
Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway
NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression
Focused ethnography of nurses' interactions and behaviours in the therapeutic positioning of patients with traumatic brain injury in Pakistan: study protocol
Pediatric kidney replacement therapies in low-to-middle income countries: a review and white paper
Evaluating the influence of maternal anti-HBs status on the antibody levels in vaccinated children
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
Structural organization of the organic sheath that delineates extracellular seta silicification in diatoms
Breastfeeding practices and exclusive breastfeeding among syrian refugee mothers in Jordanian Host Communities
Is it beneficial to allow the patient's family to attend cardiac resuscitation: Different cultural perspectives? A scoping review
Rosuvastatin restores liver tissue-resident NK cell activation in aged mice by improving mitochondrial function
High-fat diet mouse model receiving L-glucose supplementations propagates liver injury
Dental students' perceptions of integrating online learning in the dental curriculum
A pH-Dependent Phase Separation Drives Polyamine-Mediated Silicification from Undersaturated Solutions
HCC TRANSPLANT CANDIDATES' SURVIVAL ON THE WAITING LIST - CAN ORGAN UTILIZATION BE IMPROVED?
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies
Low ALT Is Associated with IBD and Disease Activity: Results from a Nationwide Study
The liver in Greco-Arabic and Islamic medicine
TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
The Lymphatic Endothelial Cell Secretome Inhibits Osteoblast Differentiation and Bone Formation
Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis
Patients with low ALT levels are at increased risk for severe COVID-19
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
The impact of obesity on postoperative complications and short-term survival after liver transplantation
Alleviation of Hepatic Steatosis by Alpha-Defensin Is Associated with Enhanced Lipolysis
Cardiorenal syndrome in the pediatric population: A systematic review
Показать ещё 42 статьи Скрыть статьи
Заболевания
Гепатит С
Рак печени
Первичный билиарный холангит
Острая печеночная порфирия
Процедуры
Трансплантация печени
Биопсия печени
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы